Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2021-01-29 2021-01-21
Drug Identification Number 02373130 02373130
Brand name XYLOCAINE 2% WITH EPINEPHRINE 1:200000 XYLOCAINE 2% WITH EPINEPHRINE 1:200000
Common or Proper name Xylocaine (lidocaine HCI 2% w/epin. 1:200M 10x20mL MD Vial) Xylocaine (lidocaine HCI 2% w/epin. 1:200M 10x20mL MD Vial)
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients LIDOCAINE HYDROCHLORIDE EPINEPHRINE LIDOCAINE HYDROCHLORIDE EPINEPHRINE
Strength(s) 20MG 0.005MG 20MG 0.005MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 10 vials 10 vials
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-01-04 2021-01-04
Estimated end date 2021-01-28 2021-01-29
Actual end date 2021-01-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments